Media - Abzena


Biotech Showcase

7 January 2019

Biotech Showcase™ is an investor conference, during JPM 2019, devoted to providing private and public biotechnology and[...] Read more

J.P Morgan’s 37th Annual Healthcare Conference

7 January 2019

Abzena will be available around the 37th staging of JP Morgan’s premier, invitation only investment conference for the[...] Read more


Antibody drug conjugates of cleavable amino-alkyl and aryl maytansinoids

Natural products have been used for many medicinal purposes for centuries. Antibody drug conjugates (ADCs) have utilized[...] Read more


Abzena Announces Expansion of Integrated Biologics Offering with the Addition of Preformulation and Formulation Capability

Dr. Jonathan Goldman, CEO, Abzena, announced that Abzena has augmented existing discovery to GMP drug substance and[...] Read more

Abzena announces 20m$ investment into expansion of integrated biotherapeutics offering (Biologics Drug Substance and ADC) and makes key executive appointment

Significant increase in capacity to 2000 L scale in new GMP facility, addition of extra cell line development capacity[...] Read more


We’re changing the way we brand our businesses

To provide our Partners with a single identity for the services and technologies offered across Antitope, PacificGMP,[...] Read more

Interested in our services? Get In Touch